Recall of Multiple Eye Drop Brands Due to Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
K.C. Pharmaceuticals, Inc. is recalling 378,144 bottles of various eye drop products, including brands like Good Sense and Walgreens, because of a lack of assurance of sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
Recall of Multiple Eye Drop Brands
What Happened
K.C. Pharmaceuticals, Inc. is initiating a voluntary recall of certain eye drop products due to a lack of assurance of sterility, which could potentially affect product safety.
Which Products Are Affected
The recall involves 378,144 bottles of tetrahydrozoline HCl 0.05% eye drops under various brand names, including Good Sense, Walgreens, Kroger, Harris Teeter, H.E.B, Rugby, Equaline, and others. Affected lots include RG24E01 with expiration 05/31/26 and RG24G02 with expiration 07/31/26, among others as specified. Specific identifiers include NDCs such as 50804-141-01 and 24385-075-05, and UPCs like 0180410000156 and 311917200736. The products were distributed nationwide in the United States.
What You Should Do
Consumers should immediately stop using the affected eye drop products and contact the recalling firm, K.C. Pharmaceuticals, Inc., at their address 3420 Pomona Blvd, Pomona, CA 91768-3236, for instructions on returns or refunds.
Why This Matters
This recall impacts a significant number of eye drop bottles across multiple brands, highlighting potential risks associated with non-sterile products that could lead to health issues if used.
Source
FDA Recall Number D-0413-2026, attributed to the FDA recall database.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,307 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.